All In MedTech

Device Trial Radar · NCT02691962

Xen Matrix™ AB Surgical Graft in Ventral or Incisional Midline Hernias

A Post-Market, Prospective, Multicenter, Single-Arm Trial of XenMatrix™ AB Surgical Graft in All Wound Classes Ventral or Incisional Midline Hernias

Last checked: Nov 20, 2026Latest source record: Oct 21, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

75

Actual

Start

May 2016

Primary completion

May 2020

Study completion May 2020

Sponsor

Lead sponsor
C. R. BardPublic (BDX)
Sponsor type
Industry
First posted
Feb 25, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to prospectively explore the use of XenMatrix™ AB Surgical Graft for ventral or incisional midline hernia repair in patients across all wound classes ("All Comers") through 24 months post repair.

Conditions

  • Incisional Hernia

Interventions

  • Xen Matrix ABDevice

    Xen Matrix™ AB Surgical Graft is an acellular, sterile, non-pyrogenic porcine dermal matrix packed dry for use in the reconstruction of soft tissue deficiencies. The device surfaces are coated with the antibacterial agents Rifampin and Minocycline in a bioresorbable L-Tyrosine succinate polymer carrier.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Wound Occurrences Up to 45 Days Post ImplantationTime frame: Up to 45 days post implantation

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Keck Hospital of USC

    Los Angeles, California

  • California Pacific Medical Center - Sutter Health

    San Francisco, California

  • Emory University

    Atlanta, Georgia

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.